Table II.
Category | Inclusion summary |
---|---|
Reproductive health | Fertility, menstruation, impotence |
Immunity | Resistance to illness, getting/becoming sick, fever |
Vitality | Energy, fitness, weakness, sleep, metabolism |
Iron | Iron levels, anaemia, supplement use |
Blood loss | Losing too much blood or inability to replenish blood supply |
Infectious disease | HIV, AIDS, malaria etc. |
Health risk/protective factors | Blood pressure, development of cancer, cardiac arrest, diabetes etc |
Physical appearance | Weight gain/loss, acne |
Improving blood | Filtering blood, reducing thickness, replenishing/purifying blood (removing old), increasing circulation |
Headache | Headaches, migraines |
Death | Dying, accelerated ageing/reduced lifespan |
Adverse events: vasovagal reactions | Fainting, dizziness, vertigo, nausea/ feeling sick/being sick, blurred vision, extreme changes in body temperature |
Adverse events: other physical | Bruising, nerve damage, tingling, convulsions, muscle spasms, allergic reactions, and other specific injuries |
Adverse events: non-specific | General mention of adverse events, feeling unwell, combination of vasovagal and other physical adverse events |
Note: there were two exceptions to weakness being coded as vitality 1) when weakness in relation to anaemia, this was coded as iron; and 2) when weakness was raised in conjunction with other vasovagal reactions this was coded as adverse events: vasovagal reactions.